• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠对异种肿瘤的组织学反应。

The histological response to a xenogeneic tumour in mice.

作者信息

Simpson E, Beverley P C

出版信息

Clin Exp Immunol. 1973 Jul;14(3):443-55.

PMID:4725398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1553819/
Abstract

We have examined, by conventional histological methods, the immune response of normal and ALS-treated mice to a tumour xenograft. In normal mice the histology of the tumour site and lymphoid organs is in agreement with the hypothesis that rejection of tumour is by a cell-mediated response. In ALS-treated mice, lymphoid organs severely depleted of small lymphocytes, show many blast cells which may be responsible for cytotoxicity. After cessation of ALS there is still a striking lack of infiltrate at the tumour site suggestive of some form of `blocking' mechanism.

摘要

我们已通过传统组织学方法,研究了正常小鼠和经抗淋巴细胞血清(ALS)处理的小鼠对肿瘤异种移植的免疫反应。在正常小鼠中,肿瘤部位和淋巴器官的组织学与肿瘤排斥是由细胞介导的反应这一假设相符。在经ALS处理的小鼠中,严重缺乏小淋巴细胞的淋巴器官出现了许多可能具有细胞毒性的母细胞。在停止使用ALS后,肿瘤部位仍明显缺乏浸润,提示存在某种形式的“阻断”机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/c144b6aba047/clinexpimmunol00284-0142-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/ea063e020ddb/clinexpimmunol00284-0134-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/ea4b51985412/clinexpimmunol00284-0134-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/9fb6e727a9aa/clinexpimmunol00284-0135-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/2780a5bb81b5/clinexpimmunol00284-0135-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/21b3ab6166dd/clinexpimmunol00284-0136-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/91eb0be7f643/clinexpimmunol00284-0137-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/a31098a77c7c/clinexpimmunol00284-0137-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/7a48e9029228/clinexpimmunol00284-0138-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/f6391987dceb/clinexpimmunol00284-0140-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/0c82642ead20/clinexpimmunol00284-0140-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/f669f49e97c1/clinexpimmunol00284-0141-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/2cf924df5b8f/clinexpimmunol00284-0141-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/c144b6aba047/clinexpimmunol00284-0142-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/ea063e020ddb/clinexpimmunol00284-0134-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/ea4b51985412/clinexpimmunol00284-0134-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/9fb6e727a9aa/clinexpimmunol00284-0135-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/2780a5bb81b5/clinexpimmunol00284-0135-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/21b3ab6166dd/clinexpimmunol00284-0136-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/91eb0be7f643/clinexpimmunol00284-0137-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/a31098a77c7c/clinexpimmunol00284-0137-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/7a48e9029228/clinexpimmunol00284-0138-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/f6391987dceb/clinexpimmunol00284-0140-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/0c82642ead20/clinexpimmunol00284-0140-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/f669f49e97c1/clinexpimmunol00284-0141-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/2cf924df5b8f/clinexpimmunol00284-0141-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ca/1553819/c144b6aba047/clinexpimmunol00284-0142-a.jpg

相似文献

1
The histological response to a xenogeneic tumour in mice.小鼠对异种肿瘤的组织学反应。
Clin Exp Immunol. 1973 Jul;14(3):443-55.
2
Serial transplantation of Burkitt's tumor (EB3) cells in newborn Syrian hamsters and its facilitation by antilymphocyte serum.伯基特氏瘤(EB3)细胞在新生叙利亚仓鼠中的连续移植及其被抗淋巴细胞血清促进的情况。
Cancer Res. 1970 Feb;30(2):338-45.
3
Effects of infant thymectomy and antilymphocyte serum on xenotransplantation of a human leukemia in the hamster.
Cancer Res. 1972 Jul;32(7):1580-3.
4
Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus.小鼠腺癌生长过程中淋巴网状组织的变化。I. 淋巴结、脾脏和胸腺的组织学与重量
J Natl Cancer Inst. 1971 Aug;47(2):301-11.
5
Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.恶性肿瘤中同种异体抗原的抑制。肿瘤易感性同种异体抗原的证据以及在微量细胞毒性试验中活跃的淋巴细胞可能存在自身反应性的证据。
Br J Cancer Suppl. 1973 Aug;1:48-61.
6
A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.免疫能力与恶性小鼠肺肿瘤皮下生长速率之间的直接关系。
Cancer Res. 1974 Apr;34(4):722-8.
7
Transplantation of allogeneic tumours in rats treated with antilymphocyte serum.用抗淋巴细胞血清治疗的大鼠同种异体肿瘤移植
Oncology. 1973;28(5):439-44. doi: 10.1159/000224846.
8
Orchidectomy and immune response.睾丸切除术与免疫反应。
Ann R Coll Surg Engl. 1976 Sep;58(5):359-67.
9
Trasylol (aprotinin) as an anti-tumour agent.抑肽酶作为一种抗肿瘤药物。
Biomedicine. 1978 Feb;29(1):1-3.
10
Transplantation behavior of Hodgkin's-like reticulum cell neoplasms of strain SJL-J mice and results of tumor reinoculation.SJL-J品系小鼠霍奇金样网状细胞瘤的移植行为及肿瘤再接种结果
J Natl Cancer Inst. 1969 May;42(5):797-807.

引用本文的文献

1
Pathological changes in the lymphoreticular tissues of Swiss mice infected with Echinococcus granulosus cysts.感染细粒棘球绦虫囊肿的瑞士小鼠淋巴网状组织的病理变化。
Z Parasitenkd. 1978 Dec 21;58(1):47-54. doi: 10.1007/BF00930791.
2
[Xenotransplantation of established tumor cells in congenital thymusless "nude" mice (author's transl)].先天性无胸腺“裸”鼠体内已建立肿瘤细胞的异种移植(作者译)
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1975;83(3):177-86. doi: 10.1007/BF00304085.

本文引用的文献

1
Thymus-dependent areas in the lymphoid organs of neonatally thymectomized mice.新生期切除胸腺小鼠淋巴器官中的胸腺依赖区。
J Exp Med. 1966 Jan 1;123(1):191-204. doi: 10.1084/jem.123.1.191.
2
Humoral responses to tumour xenografts in ALS-treated mice.对接受ALS治疗的小鼠体内肿瘤异种移植的体液免疫反应。
Int J Cancer. 1970 Nov 15;6(3):415-21. doi: 10.1002/ijc.2910060312.
3
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.肿瘤生长患者血清对细胞介导的肿瘤免疫的阻断作用。
Int J Cancer. 1971 Mar 15;7(2):226-37. doi: 10.1002/ijc.2910070206.
4
Cell-mediated responses to tumour xenografts in mice.
Int J Cancer. 1972 Mar 15;9(2):299-304. doi: 10.1002/ijc.2910090207.
5
Notes on the preparation and assay of anti-lymphocytic serum for use in mice.用于小鼠的抗淋巴细胞血清的制备及测定说明
Immunology. 1968 Nov;15(5):697-705.
6
Lymphocyte-dependent antibody in a tumor xenograft system.
Transplant Proc. 1973 Mar;5(1):161-6.
7
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.抗淋巴细胞血清对再循环淋巴细胞的选择性作用:证据与替代方法综述
Clin Exp Immunol. 1970 Jun;6(6):789-802.
8
Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation.小鼠抗胸腺细胞血清的长期给药。II. 组织病理学研究。
Clin Exp Immunol. 1971 Jul;9(1):79-98.
9
Role of thymus-derived lymphocytes in the secondary humoral immune response in mice.胸腺衍生淋巴细胞在小鼠二次体液免疫应答中的作用。
Nature. 1970 Jun 27;226(5252):1257-8. doi: 10.1038/2261257a0.